Type 2 diabetes Trials in Balatonfüred, Hungary
Conditions / Type 2 diabetes / Balatonfüred, Hungary
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02358096 | A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease | COMPLETED | PHASE2 |
| NCT02058147 | Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM | COMPLETED | PHASE3 |
| NCT00261352 | GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate | TERMINATED | PHASE3 |
| NCT00575588 | 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period | COMPLETED | PHASE3 |
| NCT00757588 | Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin | COMPLETED | PHASE3 |
| NCT00252876 | GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes | TERMINATED | PHASE3 |
| NCT05275400 | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin | COMPLETED | PHASE3 |
| NCT01619059 | Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01609582 | Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease | TERMINATED | PHASE3 |
| NCT00255645 | G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) | TERMINATED | — |